Very early researchEnded earlyNCT03338777What this trial is testingSuicide Plus Immune Gene Therapy for Advanced MelanomaWho this might be right forMelanoma Hospital Italiano de Buenos Aires 4
Large-scale testing (Phase 3)Study completedNCT02905266What this trial is testingA Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT00039572What this trial is testingBoron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the BrainWho this might be right forBrain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Study completedNCT04700072What this trial is testingSubstudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)Who this might be right forMelanoma Merck Sharp & Dohme LLC 56
Not applicableStudy completedNCT05611229What this trial is testingTreatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor BurdenWho this might be right forMetastatic Melanoma Novartis Pharmaceuticals 1,975
Very early researchStudy completedNCT01789827What this trial is testingAldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab TherapyWho this might be right forStage IV Skin Melanoma Mayo Clinic 5
Early research (Phase 1)Study completedNCT00798629What this trial is testingAdenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells MaturedWho this might be right forMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 13
Early research (Phase 1)Study completedNCT04504669What this trial is testingFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more AstraZeneca 60
Not applicableWithdrawnNCT03518229What this trial is testingPilot Study of Intervention to Reduce Sunburns in Melanoma SurvivorsWho this might be right forMelanoma (Skin) University of Minnesota
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817901What this trial is testingPhase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant MelanomaWho this might be right forUnresectable or Metastatic Melanoma Yonsei University 46
Not applicableEnded earlyNCT03073473What this trial is testingEvaluation of the NantHealth GPS Cancer Test in Patients With Advanced CancersWho this might be right forPancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more Cota Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06194929What this trial is testingDefactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaWho this might be right forCutaneous MelanomaBrain Metastases University of Utah 33
Not applicableLooking for participantsNCT05403177What this trial is testingMarathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)Who this might be right forBreast CancerColorectal CancerPancreas Cancer+9 more University Health Network, Toronto 500
Not applicableEnded earlyNCT03699995What this trial is testingMoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for MelanomaWho this might be right forCutaneous MelanomaMelanocytic NevusSkin Carcinoma OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT07288112What this trial is testingDOC1021 Dendritic Cell Immunotherapy for Refractory MelanomaWho this might be right forRefractory Melanoma Diakonos Oncology Corporation 35
Testing effectiveness (Phase 2)Study completedNCT00109005What this trial is testingLenalidomide (Revlimid) to Treat Advanced Ocular MelanomaWho this might be right forMelanoma National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01092728What this trial is testingTreatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 19
Early research (Phase 1)Study completedNCT01986426What this trial is testingLTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or PembrolizumabWho this might be right forCancerMelanomaBreast Cancer+3 more Lytix Biopharma AS 80
Not applicableStudy completedNCT02492815What this trial is testingPAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 1,773
Not applicableStudy completedNCT00049010What this trial is testingDiagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II MelanomaWho this might be right forMelanoma (Skin) Alliance for Clinical Trials in Oncology 314